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Abstract
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as a major public health problem
around the world. In Australia, ST93-IV[2B] is the dominant CA-MRSA clone and displays significantly greater virulence than other
S.aureus.Here,wehaveexamined theevolutionof ST93viagenomicanalysis of12MSSAand44MRSAST93 isolates, collected from
around Australia over a 17-year period. Comparative analysis revealed a core genome of 2.6 Mb, sharing greater than 99.7%
nucleotide identity. The accessory genome was 0.45 Mb and comprised additional mobile DNA elements, harboring resistance to
erythromycin, trimethoprim, and tetracycline. Phylogenetic inference revealed a molecular clock and suggested that a single clone of
methicillin susceptible, Panton-Valentine leukocidin (PVL) positive, ST93 S. aureus likely spread from North Western Australia in the
early 1970s, acquiring methicillin resistance at least twice in the mid 1990s. We also explored associations between genotype and
important MRSA phenotypes including oxacillin MIC and production of exotoxins (a-hemolysin [Hla], d-hemolysin [Hld], PSMa3, and
PVL). High-level expression of Hla is a signature feature of ST93 and reduced expression in eight isolates was readily explained by
mutations in the agr locus. However, subtle but significant decreases in Hld were also noted over time that coincided with decreasing
oxacillin resistanceandwere independentofagrmutations.TheevolutionofST93S.aureus is thusassociatedwitha reduction inboth
exotoxin expression and oxacillin MIC, suggesting MRSA ST93 isolates are under pressure for adaptive change.
Key words: Staphylococcus aureus, community-acquired MRSA, comparative genomics, alpha-hemolysin.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) strains are
common throughout the world (Zinn et al. 2004) and un-
til recently had been confined to hospitals. Over the past
decade, the global emergence of community-acquired
MRSA (CA-MRSA) has been a remarkable phenomenon,
dominated by the rapid emergence and spread of a clone of
CA-MRSA in the United States, called USA300 (Moran et al.
2006; Klevens et al. 2007; Kennedy et al. 2008). USA300-
0114 is ST8, SCCmec-IV and carries the genes (lukS-PV and
GBE
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lukF-PV) encoding the Panton-Valentine leukocidin (PVL).
Active case surveillance found an incidence of invasive
CA-MRSA of 4.6 per 100,000 (Klevens et al. 2007). The
USA300 clone has caused large numbers of severe SSTIs
and necrotizing pneumonias in otherwise healthy individuals
and is replacing “traditional” hospital clones of MRSA causing
severe infections in hospitalized patients while continuing to
cause serious infections in otherwise healthy individuals in the
community (Seybold et al. 2006).
USA300 possesses other virulence factors that include the
arginine catabolic mobile element that assists with bacterial
survival and is postulated to play a role in the rapid clonal
spread of USA300 and its apparent hypervirulence (Diep
and Otto 2008). However, it is difficult to be certain of the
individual contribution of any one factor, and comparative
genomic and functional assessments suggest that the in-
creased virulence of USA300 may be due to upregulation of
core virulence genes such as Hla and phenol soluble modulins
(Li et al. 2009).
In Australia, CA-MRSA first emerged in the remote
Kimberley region of Western Australia (WA, Udo et al.
1993) with Aboriginal ethnicity as a major risk factor for
CA-MRSA infection (Maguire et al. 1996). In the late
1990s, CA-MRSA infections were noted in Eastern Australia,
especially affecting the Polynesian community (Nimmo et al.
2000; Gosbell et al. 2001). Recent results from the Australian
Group on Antimicrobial Resistance (AGAR) community staph-
ylococcal surveillance program (2012) demonstrated a signif-
icant rise in MRSA in Australia, entirely due to an increased
prevalence of CA-MRSA, not hospital-associated MRSA
(AGAR 2012). A large number of clones of CA-MRSA have
been described in Australia, based on MLST and SCCmec
typing (Nimmo et al. 2006; Nimmo and Coombs 2008;
Coombs et al. 2009).
Over the past 6 years, a new clone of CA-MRSA that is
rarely reported outside Australia and was first reported
in Queensland (QLD, Munckhof et al. 2003), the ST93 QLD
clone or ST93-QLD, has become the most common CA-MRSA
clone throughout Australia (Coombs et al. 2006). In fact, the
increase in MRSA infections documented in the last AGAR
survey was due entirely to an increase in the prevalence of
the ST93-QLD CA-MRSA, a situation reminiscent of the start
of the USA300 epidemic in the United States. ST93-QLD car-
ries the SCCmec type IV[2B] element and the lukSF-PV genes
encoding PVL (Vandenesch et al. 2003). However, not all ST93
strains are alike. They are not all MRSA, and some ST93 are
PVL negative. A study using spa gene high-resolution melt
curve profiles confirmed some genetic diversity within ST93
(Tong et al. 2009).
ST93-QLD CA-MRSA is associated with severe clinical dis-
ease, and although it commonly causes significant skin and
soft tissue infections, it has also been associated with fatal
necrotizing pneumonia, bacteraemia secondary to skin infec-
tions, and deep musculoskeletal infections (Peleg and
Munckhof 2004; Peleg et al. 2005; Nourse et al. 2007;
Risson et al. 2007; Tong et al. 2008). Many of these infections
occurred in young people, including children, and some were
fatal.
We recently reported on the molecular epidemiology of
ST93 in Australia, based on an analysis of 58 isolates collected
from around Australia between 1992 and 2009 (Coombs
et al. 2012). PFGE, DNA microarray, SCCmec, and dru
typing were performed. These analyses confirmed the clonal
nature of ST93 but were unable to shed light on the popula-
tion structure and evolution of ST93. In this study, we com-
pared whole-genome sequences of 56 of these isolates to
establish a high-resolution phylogeny and evolutionary history
of this emergent S. aureus clone and investigate molecular
genetic and phenotypic variation that may explain the high
virulence and success of this clone.
Materials and Methods
Bacterial Strains and Phenotype Measurements
The 56 S. aureus ST93 isolates analyzed in this study have
been described previously (Coombs et al. 2012). However,
alternative strain names were assigned to the isolates and
these are listed in supplementary figure S1, Supplementary
Material online. Isolates were grown in Heart Infusion Broth
(Oxoid), incubated at 37 C. Oxacillin susceptibility testing
using Etest was performed according to manufacturer’s in-
structions (AB Biodisk). For d-hemolysin (Hld) expression
levels, bacteria were grown overnight at 37 C in tryptone
soy broth (TSB, Oxoid). Cultures were then diluted 1:100
into fresh media and incubation continued with shaking
(180 rpm) for approximately 24 h (OD600 2.0). Culture super-
natants were harvested by centrifugation and filter sterilized.
These assays were performed with at least biological tripli-
cates for each S. aureus isolate. Hld was measured using
high-performance liquid chromatography on an Agilent
Technology 1200 Series system with an analytical Agilent
Eclipse XDB-C18 (4.6 mm150 mm) column, coupled with
electrospray ionization mass spectrometry as described (Gao
et al. 2013).
Genome Sequencing and Analysis
Genomic DNA was extracted from all isolates and subjected to
whole-genome shotgun sequencing using an Illumina HiSeq-
2000 with 100-bp, paired-end TruSeq chemistry. Sequence
reads were submitted to National Center for Biotechnology
Information GenBank and are available under BioProject
PRJNA232112. A read mapping approach was used to align
the reads from these isolates to the S. aureus ST93-IV MRSA
JKD6159 reference genome using SHRiMP v2.0 (Rumble et al.
2009). Those positions in the reference that were covered by
at least three reads from every isolate defined a core ST93
genome. Single-nucleotide substitution polymorphisms (SNPs)
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and indels up to 10 bp and their predicted consequences on
gene function were identified using Nesoni v0.109, a Python
utility that uses the reads from each genome aligned to the
core genome to construct a tally of putative differences at
each nucleotide position (including substitutions, insertions,
and deletions) (http://bioinformatics.net.au/, last accessed
February 10, 2014) (supplementary table S1, Supplementary
Material online). To define the ST93 pan genome and inves-
tigate the total S. aureus ST93 gene content, sequence reads
for each isolate were subjected de novo assembly using Velvet
v1.2.06 (Zerbino and Birney 2008), and resulting contigs were
aligned to the JKD6159 genome with MUMmer (Kurtz et al.
2004). Sequences of at least 100 bp that were not present in
the reference genome were extracted from contigs and ap-
pended to the JKD6159 genome to construct a pan genome
sequence, which was annotated using Prokka (http://bioinfor-
matics.net.au/, last accessed February 10, 2014). The propor-
tion of the length of each annotated gene covered by reads
was assessed for each isolate and a map summarizing all var-
iable genes and their distribution in each strain produced (fig.
3, supplementary table S2, Supplementary Material online).
Phylogenetics
Phylogenetic analyses were undertaken using several
approaches. Split decomposition and neighbor-joining analy-
ses were performed using uncorrected P distances as imple-
mented in SplitsTree4 (v 4.13.1) (Huson and Bryant 2006). The
inputs for each method were the nucleotide sequence align-
ments of the concatenated variable nucleotide positions for
the core genome among all isolates, prepared using Nesoni as
described earlier and managed with SeaView v4.3.3 (Gouy
et al. 2010). A phylogeny was also inferred by maximum like-
lihood (ML) as implemented in RAxML (Stamatakis et al.
2005), using the general time reversible (GTR) model of nu-
cleotide substitution. Path-O-Gen was used to investigate the
linear association between ML root-to-tip branch lengths and
year of isolation (fig. 1) (http://tree.bio.ed.ac.uk/software/path
ogen/, last accessed February 10, 2014). BEAST v1.7.4
(Drummond and Rambaut 2007) was used to infer the evolu-
tionary dynamics of ST93 S. aureus with a GTR+ nucleotide
substitution model and tip dates defined as the year of isola-
tion. Multiple analyses were run with both constant popula-
tion size and Bayesian skyline demographic models, in
combination with either a strict molecular clock or a relaxed
clock with uncorrelated lognormal distribution. Both demo-
graphic models, using lognormal or strict clock, yielded almost
identical results. For sampling the posterior probability distri-
butions and analyses of all model combinations (demographic
and clock), ten Markov chain Monte Carlo (MCMC) chains of
100 million generations each were run to ensure convergence,
with samples taken every 1,000 MCMC generations.
Replicate analyses were combined and parameter estimates
calculated with Tracer v1.5 (Drummond and Rambaut 2007).
For phylogeographic analysis, location (the state within
Australia from which the isolate was obtained) was treated
as a discrete character trait, and ML ancestral reconstruction
was used to estimate the likely location of unsampled, ances-
tral forms of ST93. The same results were obtained using
alternative implementations of ML ancestral reconstruction
in R—the ace function in the ape package (plotted as pie
graphs in fig. 1C) and pml functions in the phangorn package.
Previously established mean exotoxin expression levels for
Hla, and PSMa3 (Chua KYL, Monk IR, Lin Y, Seemann T, Tuck
KL, Porter JL, Stepnell J, Coombs GW, Davies JK, Stinear TP,
Howden BP, submitted for publication), together with Hld
expression levels and oxacillin MICs determined in this study
were visualized alongside the ML phylogeny (fig. 2). The mean
expression levels based on biological triplicate measurements
were also compared between pairs of strains using a two-
sided, unpaired t-test on log10 transformed exotoxin expres-
sion values (GraphPad Prism V6). The null hypothesis (no
difference between means) was rejected for P<0.05. For
each MRSA isolate, mean exotoxin expression and oxacillin
MIC were compared using the nonparametric Spearman
correlation analysis (GraphPad Prism V6).
For correlation of phenotypes with phylogenies,
Felsenstein’s phylogenetically independent contrasts (PIC)
method was employed (Felsenstein 2008), and the PIC test
was performed using the R+ package “ape” (http://ape-pack
age.ird.fr/, last accessed February 10, 2014). Conventional cor-
relation tests assume data points (here, strains) are indepen-
dent, which is not the case for phylogenetically related strains,
as closely related strains may be expected to be more alike in
phenotype than distantly related strains. The PIC method
takes this into account by instead assuming that variation in
an observed variable is due to Brownian motion along the
branches in the phylogenetic tree (Felsenstein 2008).
Results
Defining a S. aureus ST93 Core Genome and Phylogeny
Alignment of sequence reads from the 56 isolates to
the S. aureus JKD6159 reference genome defined a
2,625,004 bp core genome (93.4% of the 2,811,434 bp
JKD6159 genome). Comparisons of this core genome
among all isolates identified only 519 SNPs, confirming limited
genetic diversity within this clone. An alignment of the con-
catenated variant nucleotides was then used for phylogenetic
analyses. Split decomposition analysis produced a tree with six
distinct clades and a nonnetworked topology, suggesting
recombination was not significant among this population of
isolates (fig. 1B). A rooted phylogeny was also inferred by ML,
using Staphylococcus epiderimidis R6P2A as the outgroup,
and this produced a robust tree with substantial bootstrap
support that also resolved into the same six clades as split
decomposition (fig. 1B and C). There was a significant positive
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correlation between ML root-to-tip branch lengths and dates
of isolation, suggesting substitution mutations have been oc-
curring at a regular rate (fig. 1D). There was significant geo-
graphical clustering of isolates within the phylogeny, with
most states being represented in just two phylogenetic
clades (fig. 1C). However, isolates from WA were distributed
throughout the tree, in five of the six clades, separated by
deep branching (fig. 1C). Thus, most of the diversity identified
FIG. 1.—SNP-based phylogeny of ST93 Staphylococcus aureus based on whole-genome comparisons of 56 isolates. (A) Map of Australia showing the
number of isolates and their origin by state or territory. The small inset within NSW indicates the Australian Capital Territory. (B) Unrooted neighbor-joining
phylogeny showing the presence of six clades (shaded), based on alignment of 519 SNPs using uncorrected P distances (SplitsTree4 v 4.13.1) (Huson and
Bryant 2006). (C) ML phylogeny based on the same SNP data with ancestral state reconstruction. The tree was rooted using Staphylococcus epidermidis as an
outgroup, and the log likelihood estimates for location are shown in the pie charts at each node. Tips are color coded to match the state of origin.
(D) Correlation of isolation date with ML root-to-tip branch length calculated with Path-O-Gen, showing evidence of a molecular clock-like signal in the data.
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FIG. 2.—ML phylogeny of Staphylococcus aureus ST93. Shading indicates the six phlyogenetically distinct clusters. Dating of nodes is derived from BEAST
analysis and shows acquisitions of SCCmec elements around 1995. All nodes had more than 90% bootstrap support. Phenotype data for expression of four
exotoxins (Hla; Hld; PSM; phenol soluble modulin a3; and PVL, panton valentine leukocidin) and oxacillin MIC displayed by heatmap and aligned with tree
Stinear et al. GBE
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(continued)
among ST93 was present in WA, where the clone was first
identified. This suggests that ST93 diversified in WA early on
before spreading out into other states, and ML ancestral re-
construction (pie charts in fig. 1C) supports this hypothesis.
The deep branching of Northern Territory isolates, and their
early detection in the late 1990s, suggests the origin of ST93
may lie in the north west of Australia. In contrast, isolates from
QLD clustered quite tightly, making QLD an unlikely origin for
ST93. However, the isolate collection is somewhat dominated
by relatively recent strains from 2008 and contains more iso-
lates from WA than from other states (fig. 1C), lending some
caution to this interpretation.
Estimating S. aureus ST93 Mutation Rate
We used BEAST to assess the population structure and evolu-
tionary dynamics of S. aureus ST93, including estimating mu-
tation rates and divergence times as shown in supplementary
figure S2, Supplementary Material online. The divergence
time for the most recent common ancestor of this collection
of isolates was 1973 (37 years prior to 2009, 95% highest
posterior density [HPD]: 1963–1984), and the mutation rate
(SNP/year) across the alignment was 2.3103. Scaled to
the proportion of sites, this represents within the core
genome, the approximate rate of SNP/site/year is estimated
at 4.5107 (95% HPD: 3.8107 to 5.5 107). SNPs
were also mapped back to the BEAST-inferred phylogeny to
look for homoplasies, but none were detected.
Acquisition of SCCmec and Key Accessory Elements
Two SCCmec types are represented in this collection. Isolate
TPS3106 harbors SCCmecV[5C2&5], whereas the other 43
MRSA harbor SCCmecIV[2B]. Alignment of the 22,168 bp
SCCmec IV[2B] sequence among the 43 isolates identified
only eight SNPs. This was insufficient variation to infer a very
informative phylogeny, but two of the MRSA clades identified
by whole-chromosome SNP alignments similarly clustered
in the tree inferred from the SCCmecIV[2B] SNP alignments
(fig. 2, supplementary fig. S3, Supplementary Material online).
A single acquisition of SCCmecIV[2B] is the most parsimonious
explanation for this pattern, with BEAST analysis indicating
that the MRCA of ST93 MRSA emerged around 1995,
as shown in figure 2 and supplementary figure S2,
Supplementary Material online.
All 56 isolates contained the previously described 21 kb
MW2-like plasmid (Chua et al. 2011). Alignment of the plas-
mid sequences for each isolate identified only five variable
positions, consistent with the plasmid coevolving with the
chromosome among the ST93 population as shown in sup-
plementary figure S3, Supplementary Material online.
Similarly, the 46-kb phiSA2 prophage harboring the pvl
genes was present in all isolates (except TPS3105 and
TPS3161) and sequence alignments displayed only 18 variable
positions (45,768 bp), suggesting that this prophage was pre-
sent in the MRCA of these isolates and has coevolved with
the chromosome, summarized in supplementary figure S3,
Supplementary Material online.
Linking Changes in Exotoxin Expression with Phylogeny
and Genotype
A hallmark of the reference strain JKD6159 is its high viru-
lence, linked to its robust expression of Hla (Chua et al. sub-
mitted). We were interested to explore the differential
virulence potential of the 56 isolates and to compare virulence
differences with potentially causative genetic differences.
We have previously established by quantitative Western im-
munoblotting (Chua KYL, Monk IR, Lin Y, Seemann T, Tuck
KL, Porter JL, Stepnell J, Coombs GW, Davies JK, Stinear TP,
Howden BP, submitted for publication) that the majority of
ST93 isolates produced substantial levels of Hla that were not
significantly different from each other but were above that
produced by S. aureus USA300, whereas a handful of ST93
isolates displayed reduced expression. In this study, genome
analysis revealed that four isolates with low expression levels
(TPS3105, TPS3106, TPS3151, and TPS3161) were phyloge-
netically distant from one another, but the low expression of
each isolate could explained by an independent mutation af-
fecting the agr locus (fig. 2). The agr-encoded regulator is the
major controller of Hla expression, as repair of an agrA frame-
shift mutation in TPS3105 restored expression levels and strain
virulence to that of JKD6159 (Chua KYL, Monk IR, Lin Y,
Seemann T, Tuck KL, Porter JL, Stepnell J, Coombs GW,
Davies JK, Stinear TP, Howden BP, submitted for publication).
Other than the deletion of RNAIII in TPS3106, the seven other
agr mutants had predicted amino acid substitutions in AgrC,
although only three agrC mutations were linked to reduced
Hla expression (fig. 2). None of the MSSA isolates displayed
sequence variations in agr (fig. 2). As previously reported, PVL
expression remained constant and high among all isolates,
with reduced PVL expression co-occurring with mutations in
the agr locus (fig. 2) (Coombs et al. 2012).
We also attempted to explore the links between genotype
and expression of the exotoxins PSMa-3 (previously measured)
FIG. 2.—Continued
tips. Depicted also are the positions of agrCmutations (red arrows) and two other agr mutations (orange arrows: deletion of RNAIII for TPS3106 and deletion
in agrA for TPS3105), aligned with their corresponding taxa. Inset shows neighbor-joining phylogeny derived from independent alignment of the sequences
of three key accessory elements, with tree topologies supporting acquisition and coevolution of these elements with the ST93 MRCA. A high-resolution
version of this inset figure is provided in supplementary figure S3, Supplementary Material online.
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and Hld. Low exotoxin expression was sometimes (but not
always) associated with agr mutations. TPS3106 demon-
strated relatively high levels of PSM production, despite a de-
fective agr (fig. 2). There were also instances of the inverse,
where low Hld or PSMa-3 expression occurred in the absence
of any agr mutations (TPS3139, TPS3153, TPS3171, and
TPS3183), indicating that other regulatory systems also control
expression of these genes.
Whole-Genome Comparisons of Closely Related Strains
with Divergent Exotoxin Expression
To try and ascertain the genetic basis for agr-independent
“exotoxin-low” phenotype among these four strains, we
looked for mutations within (or around) other virulence
gene regulators including rot, sarR, and saeRS relative to the
reference genome JKD6159, but no changes were found
as listed in supplementary table S1, Supplementary Material
online. We then compared phylogenetically matched pairs for
the four isolates, where the partner strain had significantly
higher exotoxin expression, to exploit their close genetic rela-
tionship and thus attempt to identify additional regulatory
controls of virulence. The findings are summarized in table 1
and provided in full detail in supplementary table S3,
Supplementary Material online. There was a diverse array of
genome changes for each pair, with no two pairs sharing
mutations in the same genes, suggesting there are multiple
pathways available to S. aureus for additional modulation of
exotoxin production. For TPS3139/3140 and TPS3171/3161,
there were less than ten genetic changes within each pair.
These differences included mutations in genes encoding hy-
pothetical proteins (or their putative promoter regions), includ-
ing a predicted transcriptional regulator (SAA6159_00471)
in TPS3171. These genes would be candidates for future func-
tional studies to explore their role in control of toxin expres-
sion. The other two isolate pairs were more distant from
each other and had a larger number of SNPs. Among the
differences between these isolates were predicted mutations
in genes encoding RpoB (A666V), and FmtC (V205G) for
TPS3183, proteins known to alter virulence and antibiotic sus-
ceptibility (Komatsuzawa et al. 2001; Gao et al. 2013), al-
though these were both quite conservative amino acid
substitutions (table 1). TPS3183 has also lost SCCmec.
Oxacillin MIC and Exotoxin Expression Are Positively
Correlated in ST93
Several recent studies have observed a link between expres-
sion of the mecA-encoded penicillin-binding protein PBP2a
and agr-controlled toxin expression, with higher levels
of PBP2a associated with reduced toxin expression through
interference with agr quorum sensing (Rudkin et al. 2012,
2014). SCCmecIV[2B] (as present in ST93 and other CA-
MRSA clones) has been linked to lower PBP2a expression,
leading to higher toxin expression (Rudkin et al. 2014). To
explore this phenomenon in ST93, we measured the oxacillin
MIC for all 56 isolates and compared these values with our
exotoxin measurements for the same isolates (figs. 2 and
3A–D). Contrary to expectations, where a higher MIC would
predict more PBP2a, leading to reduced agr activity and there-
fore reduced toxin expression, a significant positive correla-
tion was actually observed between all four exotoxins and
MIC, suggesting an inverse relationship between agr and
SCCmecIV[2B]. This relationship was most clearly evident
between Hld and MIC (fig. 3D).
Table 1
Genetically Matched Pairs with d-Toxin or PSMa3 Expression Differences
Pair
(Expression)
Strain Expression (mg/ml, MeanSD) Core Genome
Changes
Pan Genome
Changes
Comments
d-Toxin PSMa3a
1 (low) TPS3139 10.210.17b NDc 7 SNPs (2
nonsynonymous)
None One intergenic SNP u/s of SAA6159_02065,
encoding a PTS system mannitol-speciﬁc
IIBC component.1 (high) TPS3140 12.670.41 24.371.09
2 (low) TPS3147 10.780.30 3.280.93 21 SNPs, 3 InDels (3
nonsynonymous)
None Two loss-of-function mutations include a
frame-shift in SAA6159_00741, encoding a
hypothetical secreted protein, and a stop
codon in a putative ATPase,
SAA6159_02306.
2 (high) TPS3156 13.360.66 25.312.01
3 (low) TPS3171 9.711.67 ND 5 SNPs None Substitution u/s of SAA6159_00471, of a pu-
tative GntR family transcriptional regulator;
potential regulatory region for this CDS.
3 (high) TPS3169 16.080.32 9.890.46
4 (low) TPS3183 5.170.76 3.670.41 40 SNPs, 4 InDels Loss of SCCmec
in TPS3183
Nonsynonymous SNPs include RpoB (A666V),
nitrate reductase beta subunit (F427Y) and
oxacillin resistance protein FmtC (V205G).4 (high) TPS3152 13.310.83 29.794.94
aFormylated peptide.
bAll expression values were signiﬁcantly different (P< 0.01) except for d-toxin expression between 3,139 and 3,140.
cNot detected.
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Decreasing Oxacillin MIC and Exotoxin Expression
Over Time
We also examined the change in oxacillin MIC over the
evolution of this ST93 strain collection. A modest but signifi-
cant correlation was observed between MIC and ML phylog-
eny root-to-tip branch length, suggesting that MICs are
decreasing as the complex evolves (fig. 3E). This relationship
is visually evident in the alignment of mean MIC values, dis-
played as a heatmap and aligned with the ML phylogeny
as shown in figure 2. A similar, significant relationship was
also observed between Hld expression and branch length
(figs. 2 and 3F), underscoring the link between SCCmec
FIG. 3.—Exotoxin expression among 43 ST93 MRSA isolates compared with oxacillin MIC and evolutionary distance. Correlation of (A) Hla, (B) PSMa3,
(C) Hld, and (D) PVL expression with oxacillin MIC. Shown is Spearman’s rank correlation coefficient (r) and significance indicated with a two-sided P value.
Correlation of ML root-to-tip distance with (E) oxacillin MIC and (F) Hld are also shown. Assessment of the significance of these relationships was also
measured using Felsenstein’s PIC method (Felsenstein 2008). The correlation coefficient of this statistic is indicated by rpic.
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and agr-regulated virulence gene expression, and suggesting
that this clone is undergoing adaptive change.
ST93 Pan-Genome Analysis
Analysis of the 3.02 Mb ST93 pan genome showed only lim-
ited variability among the 56 isolates as depicted in figure 4,
supplementary figure S1 and table S2, Supplementary
Material online, again consistent with the recent dissemina-
tion of ST93. However, several important accessory elements
were variously present, including two prophage, one resem-
bling phage96 (ST93P_02827–ST93P_02903) (Kwan et al.
2005), and ten occurrences of another large phage of un-
known function (ST93P_02719–ST93P_02767). Key features
were the presence in ten isolates of a pNE131-like plasmid
harboring the ermC gene (ST93P_02678), encoding erythro-
mycin resistance (Lampson and Parisi 1986). The distribution
of this plasmid among isolates dispersed across the core
genome phylogeny suggests this plasmid has been acquired
on several occasions. Other independent gene acquisitions
include dfhR (STP93_02815) conferring trimethoprim resis-
tance (Rouch et al. 1989), tetK (STP93_02803) encoding
tetracycline resistance (Khan and Novick 1983), and three
instances of qacC (STP93_02677), responsible for increased
tolerance to quaternary ammonium compounds and beta-
lactam antibiotics (Fuentes et al. 2005).
The pan genome data aligned well with previous PFGE and
DNA microarray analysis (Coombs et al. 2012). However,
there were also some differences as shown in supplementary
figure S1, Supplementary Material online. Accessory genome
variations as revealed by the pan genome analysis, in particular
the different phage content, likely explains the different PFGE
types previously described for this clone (fig. 4). These data
are described in more detail in supplementary figure 1 and
table S2, Supplementary Material online.
Discussion
The emergence of CA-MRSA as an important pathogen has
occurred over the past 2 decades (David and Daum 2010;
DeLeo et al. 2010). Although much attention has focused
on the USA300 epidemic in the Unites States (Uhlemann
et al. 2013), globally a number of other important but genet-
ically distinct clones of CA-MRSA have been reported (Chua,
Laurent, et al. 2011). A recent study described the population
structure and evolutionary history of the emerging CA-MRSA
clonal complex 97, and the evidence for several bovine-to-
human adaptive leaps within this lineage of S. aureus (Spoor
et al. 2013). Identifying drivers of CA-MRSA evolution, such as
human–livestock interactions will be key to understanding and
attempting to control the spread of new S. aureus clones
(Shepheard et al. 2013). In Australia, a geographically isolated
continent, ST93 has become the dominant clone of CA-
MRSA, with clinical and epidemiological features reminiscent
of early reports of the USA300 epidemic in the Unites States,
including rapid emergence and epidemiological dominance in
addition to severe clinical manifestations (Peleg and Munckhof
2004; Peleg et al. 2005; Chua et al. 2011; AGAR 2012;
Coombs et al. 2012). This has led to concern regarding the
origin of ST93 S. aureus, including the dynamics of acquired
methicillin resistance, and the virulence potential of the ST93
population in Australia. Staphylococcus aureus is known to
cause clonal epidemic waves of infection, such as that
caused by phage type 80/81 in the 1950s (DeLeo et al.
2011), and detailed comparative genomics is starting to pro-
vide important insights into the molecular basis of S. aureus
virulence and the epidemiology of S. aureus infections
(Kennedy et al. 2008; DeLeo et al. 2011; McAdam et al.
2012). Here, we have used genomics to enhance our under-
standing of the population structure and evolution of ST93
CA-MRSA from Australia, providing new insights into the
emergence of this clone. We found limited DNA sequence
diversity despite the geographic distribution of our sample
collection, suggesting that ST93 is a recently emerged clone.
In fact, the total number of SNPs in the core genome (2.6 Mb)
of our 56 ST93 isolates was restricted to 519. Using align-
ments of core genome SNPs and analysis with BEAST, we
estimated a mutation rate that is 10–20 times less than
rates previously reported for other S. aureus clones (Harris
et al. 2010; Nubel et al. 2010; Kurt et al. 2013). The signifi-
cance of this difference is not known and may represent a
clone-specific phenomenon. Our phylogeographic analysis in-
dicates the origins of present-day ST93 CA-MRSA around
Australia was a single-methicillin-sensitive, PVL-positive ST93
S. aureus ancestor, which emerged in North WA in the 1960s.
This is consistent with the earliest records of ST93 S. aureus,
which was first reported in this region in 1993 (Udo et al.
1993), followed by later reports in QLD (Munckhof
et al. 2003) and other states (Nimmo et al. 2000; Gosbell
et al. 2001).
Previously, we fully sequenced and finished a highly virulent
ST93 strain, JKD6159 (Chua et al. 2011). Despite the substan-
tial genetic diversity of this clone compared with other fully
sequenced S. aureus, very few clone-specific coding se-
quences were identified. We investigated the accessory ele-
ments of the whole ST93 S. aureus population using a pan
genome analysis of all isolates in this study (fig. 4). The pan
genome was 3 Mb and comprised additional mobile DNA el-
ements typically identified in S. aureus, harboring resistance
elements to erythromycin (ermC), trimethoprim (dfhR), and
tetracycline (tetK). Erythromycin resistance was independently
acquired by multiple MSSA and MRSA strains, whereas tetK
was restricted to one strain (TPS3151) and dfhR to one strain
(TPS3161). Characterization of the SCCmec element identi-
fied two unique mec types, with phylogeny of the mec ele-
ments indicating two unique SCCmec acquisitions in the study
population, followed by clonal expansion of MRSA, predom-
inately containing SCCmec IV[2B]. Repeated SCCmec acquisi-
tion cannot be ruled out, as has been previously suggested in
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this clone (Tong et al. 2009), but this seems less likely. Loss of
PVL phage was observed for strains TPS3161 and TPS3105,
and loss of SCCmec for strain TPS3183.
In this study, we also investigated the virulence character-
istics of the isolate collection by measuring exotoxin expres-
sion, including PVL, Hla, Hld, and PSMa3. Our reference ST93
CA-MRSA strain JKD6159 has been shown to be the most
virulent global isolate of S. aureus tested to date in both skin
and sepsis models (Chua et al. 2011; Tong et al. 2013), there-
fore understanding the genomic mediators of virulence in this
clone is likely to uncover important features of S. aureus viru-
lence. A large number of distinct CA-MRSA clones have now
been fully sequenced, and to date, no single gene or locus has
been discovered to account for the enhanced virulence of
these clones compared with hospital type MRSA. In fact,
rather than enhanced virulence being explained by the addi-
tion of virulence factors, virulent CA-MRSA may represent
“cleanskin” S. aureus that has been relatively unexposed
and unaffected by the selective pressures of antibiotics and
the hospital environment (Uhlemann et al. 2013) and has
therefore not acquired virulence tempering mutations. It has
been clearly demonstrated that accumulation of agr muta-
tions is associated with MRSA adaptation to the hospital en-
vironment (Shopsin et al. 2008; Fitzgerald 2013), possibly as
an adaptive response to antibiotic exposure (Paulander et al.
2013). Additionally, in the CC30 clone, it appears that muta-
tions in hla, agrC, and possibly crtM (squalene desaturase) are
associated with the loss of virulence and evolution toward a
healthcare-associated clone with epidemic potential (DeLeo
et al. 2011; McAdam et al. 2012). On the other hand,
recent epidemic clones, such as ST22, are also highly success-
ful and do not harbor these mutations (Holden et al. 2013).
Although ST93 is currently recognized as a community MRSA
clone, using analysis of exotoxin expression, we have detected
an evolutionary trend toward reduced virulence and lower
MIC, and the acquisition of eight independent agr mutations
in the 56 isolates from this study may indicate adaptation to
health care environments. The virulence analysis highlights a
number of important features. First, despite the relative ge-
netic homogeneity of the isolate collection, significant differ-
ences in exotoxin expression were also observed, suggesting
that the potential to cause severe clinical disease would be
different in these isolates. So, although generalizations about
the virulence characteristics of a particular clone of S. aureus
can be made, individual isolates within an MLST-defined
clonal group can behave very differently, and these differences
are not solely explained by agr mutations. Future studies in-
vestigating the virulence characteristics of a clone need to
keep this in mind and present data from a number of repre-
sentative isolates. In addition, although JKD6159 has been
most extensively studied and found to be distinctive in its
high virulence capacity, many other strains from this collection
produced similar amounts of Hla to JKD6159 but significantly
more PSMa3, as shown in figure 2 (TPS3138, TPS3146, and
TPS3166), possibly indicating they could be even more
virulent.
The high virulence potential of individual clones should also
be considered in the context of the ST93 population, where
there was a significant trend toward reduced agr activity, as
indicated by the correlation between evolutionary recent iso-
lates and reduced Hld expression (figs. 2 and 3F). These data
suggest that the ST93 population is under pressure to change.
Reduced virulence over time is typical of hospital-associated
MRSA and is thought to reflect adaptation to health care
settings (DeLeo et al. 2011). Perhaps, the presence of this
phenotype in ST93 CA-MRSA indicates reduction in virulence
is a more generalizable trait of MRSA, where acquisition of
SCCmec leads to alteration of agr function (and perhaps
other regulators) and subsequent adaptive changes to
obtain a regulatory homeostasis, balancing the impact of car-
rying SCCmec on gene regulation with bacterial cell functions
required for persistence in human populations. The significant
positive correlations between expression of exotoxins and ox-
acillin MIC are consistent with an interaction between agr and
SCCmec (fig. 3A–D). Recent studies have reported a link be-
tween oxacillin MIC and agr, where PBP2a (mecA)-induced
cell wall changes are proposed to interfere with the ability
of the agr system to sense autoinducing peptide (Rudkin
et al. 2012, 2014). This model predicts that agr activity will
increase as oxacillin MIC decreases. However, this is the in-
verse relationship to the positive correlation between oxacillin
MIC and agr function (using Hld production as a marker of agr
activity) that we have observed (fig. 3D). Future research mea-
suring RNAIII and mecA expression levels among our ST93
strain collection might provide a more direct exploration of
this relationship.
The ST93 population structure uncovered from this strain
collection suggested region specific clonal expansion (fig. 1),
indicative of the establishment of localized populations and
local transmission. However, significant ongoing country-
wide mixing also seems to be occurring, reminiscent of the
pattern of Enterococcus faecium movement around Australia
(Howden et al. 2013). Investigating the movement of ST93 CA-
MRSA could be more comprehensively addressed with a larger
isolate collection that is prospectively collected and supported
with detailed microbiological and epidemiological data.
Supplementary Material
Supplementary tables S1–S3 and figures S1–S3 are available
at Genome Biology and Evolution online (http://www.gbe.
oxfordjournals.org/).
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